A novel mechanism for skeletal resistance in uremia

Kidney International

Volumn 58, Issue 2, 2000, Pages 753-761

  Slatopolsky, E ^a   Finch, J ^a   Clay, P ^a   Martin, D ^a   Sicard, G ^a   Singer, G ^a   Gao, P ^a   Cantor, T ^a   Dusso, A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adynamic bone disease; Chronic renal failure; IRMA for PTH; Parathyroid; Secondary hyperparathyroidism

Indexed keywords

CALCIUM; CYCLIC AMP; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETON; UREMIA;

EID: 0033860423     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00222.x     Document Type: Article

References (31)

1. Complete amino acid sequence of human parathyroid hormone
2. Pre-pro-parathyroid hormone: Evidence for an early biosynthetic precursor of pro-parathyroid hormone
3. Pre-pro-parathyroid hormone: Amino acid sequence, chemical synthesis and some biological studies of the precursor region
4. Conversion of pro-parathyroid hormone to parathyroid hormone: The use of amines as specific inhibitors
5. Regulation of parathyroid hormone secretion: Proportional control by calcium: Lack of effect of phosphate
6. Relationship of low blood calcium to parathyroid secretion
7. Studies on the biosynthesis of rat parathyroid hormone and pro-parathryoid hormone: Adaption of the parathyroid gland to dietary restriction of calcium
8. Calcium dependent intracellular degradation of parathyroid hormone: A possible mechanism for the regulation of hormone stores
9. Vitamin D, parathyroid hormone, and the renal osteodystrophies
10. Hyperparathyroidism in renal failure: Clinical features, diagnosis, and management
11. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia
12. Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay
13. Towards immunoassays of greater sensitivity, specificity and speed: An overview
14. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathryoidism
15. Clinical performance of parathyroid hormone immunometric assays
16. Metabolism of immunoreactive parathyroid hormone in the dog: The role of the kidney and the effects of chronic renal disease
17. Impaired parathyroid hormone metabolism in patients with chronic renal failure
18. The peripheral metabolism of parathyroid hormone
19. Effects of hepatectomy, nephrectomy, and nephrectomy/uremia on the metabolism of parathyroid hormone in the rats
20. Metabolism of radioiodinated carboxy terminal fragments of bovine parathyroid hormone in normal and anephric rats
21. Radioimmunoassay of the middle region of human parathyroid hormone using an homologous antiserum with carboxyl-terminal fragment of bovine parathyroid hormone as radio/ligand
22. Intact parathyroid hormone overestimates the presence and severity of parathyroid mediated osseous abnormalities in uremia
23. Relationship between 1 and 84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
24. A non-(1-84) circulating parathyroid hormone fragment interferes significantly with intact PTH commercial assay measurement in uremic samples
25. Carboxyl-terminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidisim as they are in other causes of hypercalcemia
26. Radioimmunoassay for the measurement of adenosine 3'-5' cyclic phosphate
27. Eine einfache colorimetrische methode zur inulinbestimmung fur nieren-clearance-untersuchungen bei stoffwechselgesunden und diabetikern
28. Skeletal resistance to endogenous parathyroid hormone in patients with early renal failure, a possible cause for secondary hyperparathyroidism
29. Dialysis osteodystrophy: A study involving 94 patients
30. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease
31. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure